About Cala Health
Cala Health is a company based in Stanford (United States) founded in 2013 by Kate Rosenbluth. Cala Health has raised $257.05 million across 9 funding rounds from investors including Novartis, Johnson & Johnson and SK biopharmaceuticals. Cala Health offers products and services including Cala kIQ System, Cala TAPS Therapy, and Cala Trio System. Cala Health operates in a competitive market with competitors including Ceribell, Kernel, PhotoPharmics, Rhaeos and Spark Biomedical, among others.
- Headquarter Stanford, United States
- Founders Kate Rosenbluth
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cala Health, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$257.05 M (USD)
in 9 rounds
-
Latest Funding Round
Not available
-
Investors
Novartis
& 24 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cala Health
Cala Health offers a comprehensive portfolio of products and services, including Cala kIQ System, Cala TAPS Therapy, and Cala Trio System.
FDA-cleared device for reducing hand tremors in essential tremor patients.
Non-invasive stimulation therapy to alleviate action tremors effectively.
Wearable solution for tremor relief in Parkinson’s disease users.
People of Cala Health
Unlock access to complete
Funding Insights of Cala Health
Cala Health has successfully raised a total of $257.05M across 9 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cala Health
Cala Health has secured backing from 25 investors, including venture fund and institutional investors. Prominent investors backing the company include Novartis, Johnson & Johnson and SK biopharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early & late stage investments focused PE & VC firm
|
Locked | Locked | Locked | |
|
Investments are focused on neurotechnology for brain disorders.
|
Locked | Locked | Locked | |
|
Stage-agnostic investments in US life sciences are pursued.
|
Locked | Locked | Locked |
Investor details for Cala Health
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cala Health
Investment portfolio details for Cala Health
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cala Health
Detailed financials for Cala Health
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cala Health Comparisons
Peer comparison for Cala Health
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cala Health
Cala Health operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ceribell, Kernel, PhotoPharmics, Rhaeos and Spark Biomedical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Portable EEG devices for point-of-care seizure diagnosis are provided.
|
|
| Locked | Locked | Locked |
Multimodal brain measurement technology is developed for neuromedicine applications.
|
|
| Locked | Locked | Locked |
Non-invasive phototherapy for Parkinson's disease is developed.
|
|
| Locked | Locked | Locked |
Noninvasive device developed for CSF monitoring and hydrocephalus management.
|
|
| Locked | Locked | Locked |
Neurostimulation devices for opioid withdrawal symptoms are developed.
|
Detailed competitors of Cala Health
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cala Health
Complete news archive for Cala Health
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cala Health
Cala Health was founded in 2013.
Cala Health is headquartered in Stanford, United States. It is registered at Stanford, California, United States.
Deanna Harshbarger is the current CEO of Cala Health.
Cala Health is a funded company, having raised a total of $257.05M across 9 funding rounds to date.
Cala Health was founded in 2013 in Stanford, United States, and operates in the medical devices sector focused on neuromodulation. A watch-like wearable device combined with an implantable sensor is developed to stimulate peripheral nerves and reduce hand tremors in adults with essential tremors. Additionally, a portable device equipped with sensors is created to monitor patient physical movements.
Cala Health's top competitors include Ceribell, Magnus Medical and PhotoPharmics.
Cala Health offers Cala kIQ System, Cala TAPS Therapy, and Cala Trio System.
Cala Health has 25 investors. Key investors include Novartis, Johnson & Johnson, SK biopharmaceuticals, Vertex Growth, and Nexus NeuroTech Ventures.